01Cresco Labs reported Q3 2026 EPS of -$0.03, missing the consensus estimate of -$0.02 by $0.01 per share.
02Revenue was $172.8 million, falling short of the $173.7 million estimate by $0.9 million.
03The 50% miss on EPS relative to consensus represents a notable deviation that often triggers analyst revisions.
04Cresco Labs showed significant earnings volatility, with Q2 2026 delivering a +300% surprise versus estimate.
Earnings Results
Cresco Labs (NASDAQ:CRLBF) reported quarterly earnings results on November 06, 2026 that fell short of analyst expectations.
The company reported earnings per share of $-0.03, missing the consensus estimate of $-0.02 by $0.01 per share. Revenue came in at $172.8M, missing the estimate of $173.7M.
Company Overview
Cresco Labs's stock moved following the earnings release.
Missing analyst estimates puts pressure on a stock as investors reassess their growth assumptions. The market's reaction to an earnings miss depends heavily on the magnitude of the shortfall, the company's forward guidance, and whether the miss was driven by temporary or structural factors.
The 50% miss relative to consensus estimates is a notable deviation. Earnings surprises of this magnitude often trigger analyst revisions and can influence institutional positioning in the weeks following the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Cresco Labs should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.